Pfizer Inc. (PFE.DE)

26,91 -0,11 (-0,41%) Börsenschluss: 05:35PM CEST

Pfizer Inc.

66 Hudson Boulevard East
New York, NY 10001-2192
United States
212 733 2323
https://www.pfizer.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - General
Vollzeitmitarbeiter: 88.000

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Albert Bourla D.V.M., Ph.D.	Chairman of the Board & CEO	3,73M	N/A	1962
Mr. David M. Denton	Chief Financial Officer & Executive VP	1,61M	N/A	1965
Dr. Mikael Dolsten M.D., Ph.D.	Chief Scientific Officer and President of Research & Development	2,22M	N/A	1958
Mr. Douglas M. Lankler	Executive VP & General Counsel	1,62M	N/A	1966
Ms. Susan Michele Silbermann	Global President of Vaccines	N/A	N/A	1962
Ms. Margaret M. Madden	Senior VP, Corporate Secretary & Chief Governance Counsel	N/A	N/A	N/A
Mr. Nick Lagunowich	Global President of Internal Medicine	N/A	N/A	N/A
Mr. Paul Levesque	Global President of Pfizer Rare Disease	N/A	N/A	N/A
Paivi Kerkola	Chief Executive Officer of Pfizer Italy	N/A	N/A	N/A
Mr. Ronen Tamir	Vice President of Investor Relations	N/A	N/A	1967

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Corporate Governance

Pfizer Inc.s ISS Governance QualityScore, Stand 1. Juni 2024, lautet 7. Die grundlegenden Scores sind Audit: 10, Vorstand: 8, Shareholderrechte: 1, Kompensation: 7.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.